The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview

Pancreatic ductal adenocarcinoma (PDAC) has one of the highest mortality rates among all cancer types. Its delayed diagnosis precludes curative resection, thus most of the current therapies against PDAC are based on chemo- and radiotherapy. Unfortunately, these strategies are insufficient to improve...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Biol Med
Päätekijät: Quiñonero, Francisco, Mesas, Cristina, Doello, Kevin, Cabeza, Laura, Perazzoli, Gloria, Jimenez-Luna, Cristina, Rama, Ana Rosa, Melguizo, Consolación, Prados, Jose
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Chinese Anti-Cancer Association 2019
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6936232/
https://ncbi.nlm.nih.gov/pubmed/31908888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2019.0252
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia